European Society For Medical Oncology (ESMO)

The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]

The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. Scheduled for March 6–7, 2026, in Zurich, Switzerland, the course focuses on multidisciplinary care, […]

The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […]

The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […]

The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development. The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The […]

The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.” This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the […]

The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […]

The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28, 2026, in Beijing, China. Co-chaired by Giuseppe Curigliano and Binghe Xu, this 1.5-day course is specifically designed for experienced oncologists and oncology […]

The ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota is a two-day educational course aimed primarily at oncologists resident in Latin America. It will be held from April 15–16, 2026, in Bogota, Colombia. The application deadline for this preceptorship is February 1, 2026, at 23:59 CET. Successful applicants receive complimentary course registration and accommodation, and a […]

The ESMO Preceptorship on Breast Cancer 2026: Bogota is an educational course scheduled for April 15–16, 2026, in Bogotá, Colombia. Co-chaired by Carlos Barrios and Nadia Harbeck, this intensive meeting is primarily aimed at oncologists in Latin America to foster interdisciplinary collaboration and improve subtype-specific breast cancer management. The technical program covers the latest advancements […]